Efficacy and Safety of Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive (PH+) Chronic Myeloid Leukemia (CML): Results from A PHASE 2 Trial - Hijiya, N; Maschan, A; Rizzari, C (Pediatr Blood Cancer, 2017)
(e26772)